PROFIL PENGOBATAN PASIEN DIABETES MELITUS TIPE 2 KARTU JAKARTA SEHAT YANG MENJADI PASIEN BPJS DI RSUD TARAKAN JAKARTA

Nanang Erlana

Abstract


Kartu Jakarta sehat (KJS) is also a health care insurance program provided by the Provincial Government of DKI Jakarta through UP Jamkesda (Regional Health Insurance) DKI Jakarta Provincial Health Office to the community in the form of medical assistance using Essential Service Package / PPE method. DKI Jakarta Provincial Government, has merged the Kartu Jakarta Sehat (KJS) with National Health Insurance (JKN) which was officially applied as of January 1, 2014. The owner of Jamkesda DKI card / Kartu Jakarta Sehat which is a free health program for the poor, BPJS Health. Diabetes Mellitus is one of the chronic diseases that require comprehensive services and the number is always increasing every year. Treatment of Diabetes Mellitus should be done routinely and the outcome of therapy or clinical outcome needs to be monitored in a planned manner. The purpose of this research is to know the difference of treatment profile before and after the implementation of JKN in patient of Diabetes Mellitus type 2 Kartu Jakarta Sehat in RSUD Tarakan Jakarta. The study was conducted in longitudinal time series, restrospectively collecting data from patient medical records and Hospital Pharmacy Installations from January 2013 to December 2014 for patients who met the inclusion criteria. The results showed no difference in total drug, DM drug, non-DM drug, generic drug and drug of Fornas. Based on these results it can be concluded that the profile of treatment in patients with type 2 diabetes Kartu Jakarta Sehat did not change after the implementation of  National Health Insurance (JKN).


Keywords


E-Catalog, Drug Price, RSUD Tarakan Jakarta

Full Text:

PDF

References


Association Diabetic American. 2014. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, Volume 37, Supplement 1, January 2014, hal. S14-27

American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care Volume 37, Suplement 1, Januari 2014:S14-S80.

Brunton L.L. 2011. Goodman and Gilman᾽s The Pharmacological Basis of Therapeutics. 12th Edition. Mc Graw Hill Medical.

Budiman B., Dewi M., Julianti ED., Yovita TA., Purwanto E. Riset Kesehatan Dasar Dalam Angka Provinsi DKI Jakarta. Kementerian Kesehatan Republik Indonesia. Jakarta 2013. Halaman 51, 121,123.

Holt T., Kumar S. ABC of Diabetes. Sixth Edition. Chicester. West Sussex: Wily-Blackwel. A John Wiley & Sons, Ltd.

Katzung, B.G. 2009. Basic and Clinical Pharmacologi. 11th Edition. MC Graw Hill Medical.

Kementerian Kesehatan(b). 2010. Peraturan Menteri Kesehatan Republik Indonesia Nomor HK.02.02/Menkes/068/I/2010 tentang Kewajiban Menggunakan Obat Generik di Fasilitas Pelayanan Kesehatan Pemerintah. Jakarta.

Kementerian Kesehatan Republik Indonesia(c). 2014. Peraturan Menteri Kesehatan Republik Indonesia Nomor 63 Tahun 2014 tentang Pengadaan Obat Berdasarkan Katalog Elektronik (E-Catalogue). Jakarta.

Levine JP. Type 2 Diabetes Among Women : Clinical consideration for Pharmacological Management to Achive Glicemic Control and Reduce Cardiovascular Risk. Journal of Women᾽s Health. Volume 17. Number 2.

Peraturan Gubernur Provinsi Daerah Khusus Ibukota Jakarta Nomor 14 tahun 2013 tentang Perubahan Atas Peraturan Gubernur Nomor 187 tahun 2012 tentang Pembebasan biaya Pelayanan Kesehatan. Jakarta.

Perkumpulan Endokrinologi Indonesia (PERKENI). 2011. Konsensus Pengelolaan dan Pencegahan Diabetes Mellitus Tipe 2 di Indonesia.

Pontoan J. 2015. Evaluasi Profil Pengobatan dan Biaya, Clinical Outcomes Sebelum dan Sesudah JKN serta HRQOL pada Pasien DM Tipe 2 di RSUD Tarakan Jakarta (Tesis). Jakarta: Fakultas Farmasi Universitas Pancasila.




DOI: https://doi.org/10.52447/scpij.v2i2.1051

Refbacks

  • There are currently no refbacks.